News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,965 Results
Type
Article (50694)
Company Profile (342)
Press Release (640929)
Section
Business (197452)
Career Advice (2856)
Deals (34746)
Drug Delivery (103)
Drug Development (80664)
Employer Resources (168)
FDA (16443)
Job Trends (15498)
News (336406)
Policy (31508)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (11)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (6)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (12)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2885)
Academic (1)
Accelerated approval (2)
Adcomms (25)
Allergies (84)
Alliances (50235)
ALS (93)
Alzheimer's disease (1445)
Antibody-drug conjugate (ADC) (127)
Approvals (16431)
Artificial intelligence (254)
Autoimmune disease (20)
Automation (14)
Bankruptcy (328)
Best Places to Work (12353)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (241)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (261)
Cancer (2078)
Cardiovascular disease (177)
Career advice (2377)
Career pathing (33)
CAR-T (154)
Cell therapy (433)
Cervical cancer (20)
Clinical research (65019)
Collaboration (831)
Compensation (463)
Complete response letters (24)
COVID-19 (2767)
CRISPR (42)
C-suite (224)
Cystic fibrosis (104)
Data (1994)
Decentralized trials (2)
Denatured (25)
Depression (47)
Diabetes (258)
Diagnostics (6752)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (116)
Drug pricing (95)
Drug shortages (21)
Duchenne muscular dystrophy (88)
Earnings (76808)
Editorial (37)
Employer branding (21)
Employer resources (148)
Events (111153)
Executive appointments (681)
FDA (17586)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (728)
Gene editing (109)
Generative AI (23)
Gene therapy (308)
GLP-1 (741)
Government (4514)
Grass and pollen (3)
Guidances (46)
Healthcare (20281)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (122)
Indications (27)
Infectious disease (2903)
Inflammatory bowel disease (144)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (90)
Interviews (550)
IPO (16859)
IRA (37)
Job creations (3614)
Job search strategy (1983)
Kidney cancer (10)
Labor market (27)
Layoffs (498)
Leadership (20)
Legal (6960)
Liver cancer (70)
Lung cancer (296)
Lymphoma (130)
Machine learning (4)
Management (61)
Manufacturing (284)
MASH (66)
Medical device (14301)
Medtech (14306)
Mergers & acquisitions (18414)
Metabolic disorders (663)
Multiple sclerosis (72)
NASH (17)
Neurodegenerative disease (95)
Neuropsychiatric disorders (29)
Neuroscience (1964)
NextGen: Class of 2025 (7217)
Non-profit (4939)
Northern California (2476)
Now hiring (33)
Obesity (351)
Opinion (251)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (78)
Parkinson's disease (142)
Partnered (21)
Patents (215)
Patient recruitment (97)
Peanut (49)
People (58129)
Pharmaceutical (82)
Pharmacy benefit managers (19)
Phase I (20529)
Phase II (28884)
Phase III (21360)
Pipeline (1065)
Podcasts (72)
Policy (110)
Postmarket research (2215)
Preclinical (8671)
Press Release (71)
Prostate cancer (95)
Psychedelics (33)
Radiopharmaceuticals (266)
Rare diseases (387)
Real estate (5948)
Recruiting (68)
Regulatory (22071)
Reports (31)
Research institute (2587)
Resumes & cover letters (454)
Rett syndrome (3)
RNA editing (4)
RSV (44)
Schizophrenia (73)
Series A (128)
Series B (82)
Service/supplier (11)
Sickle cell disease (56)
Southern California (2158)
Special edition (17)
Spinal muscular atrophy (153)
Sponsored (32)
Startups (3794)
State (2)
Stomach cancer (12)
Supply chain (62)
The Weekly (44)
United States (22053)
Vaccines (728)
Venture capitalists (33)
Webinars (11)
Weight loss (243)
Women's health (31)
Worklife (17)
Date
Today (252)
Last 7 days (735)
Last 30 days (2888)
Last 365 days (35385)
2025 (8457)
2024 (37071)
2023 (42137)
2022 (53544)
2021 (58288)
2020 (56933)
2019 (50133)
2018 (38014)
2017 (34407)
2016 (33571)
2015 (39078)
2014 (30232)
2013 (24921)
2012 (26478)
2011 (27017)
2010 (23965)
Location
Africa (887)
Alabama (56)
Alaska (7)
Arizona (175)
Arkansas (13)
Asia (41354)
Australia (7240)
California (5697)
Canada (1898)
China (498)
Colorado (256)
Connecticut (275)
Delaware (132)
Europe (94256)
Florida (841)
Georgia (206)
Idaho (60)
Illinois (540)
India (23)
Indiana (305)
Iowa (8)
Japan (143)
Kansas (103)
Kentucky (26)
Louisiana (9)
Maine (68)
Maryland (859)
Massachusetts (4393)
Michigan (230)
Minnesota (390)
Mississippi (2)
Missouri (82)
Montana (31)
Nebraska (26)
Nevada (57)
New Hampshire (68)
New Jersey (1631)
New Mexico (31)
New York (1634)
North Carolina (1022)
North Dakota (8)
Northern California (2476)
Ohio (201)
Oklahoma (15)
Oregon (36)
Pennsylvania (1280)
Puerto Rico (9)
Rhode Island (27)
South America (1208)
South Carolina (19)
South Dakota (1)
Southern California (2158)
Tennessee (94)
Texas (846)
Utah (175)
Virginia (140)
Washington D.C. (60)
Washington State (539)
West Virginia (3)
Wisconsin (59)
691,965 Results for "karolinska development ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
AB Science SA is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development.
March 7, 2024
·
11 min read
Press Releases
Nemysis Limited Announces Collaboration With Avia Pharma AB as IHAT Distributor in Nordic Region
March 14, 2025
·
2 min read
Press Releases
Candid Therapeutics and Ab Studio Enter Into Research Collaboration to Discover and Develop Novel T Cell Engagers for Autoimmune Indications
December 16, 2024
·
2 min read
Press Releases
AB Science will participate in the Biomed Forum investors conference
January 22, 2025
·
2 min read
Press Releases
AB Science today provides an update on its masitinib platform
January 30, 2025
·
4 min read
XNK Therapeutics enters into research collaboration with Karolinska University Hospital in acute myeloid leukemia (AML)
XNK Therapeutics AB announced that the company has entered into a research collaboration with the Karolinska University Hospital, Sweden, to evaluate the suitability of the company’s autologous natural killer cell therapy candidate XNK02 as a novel therapy for treatment of acute myeloid leukemia.
August 24, 2023
·
3 min read
Business
Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology
Anocca AB and Shinobi Therapeutics announced a strategic partnership to use Shinobi’s proprietary immune evasive iPS-T cell platform with novel candidate TCRs, discovered and validated by Anocca, to develop a new class of off-the-shelf allogeneic TCR engineered iPS-T-cell therapies for solid tumors.
May 30, 2024
·
4 min read
Press Releases
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108
March 17, 2025
·
5 min read
Press Releases
Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB
February 6, 2025
·
7 min read
1 of 69,197
Next
